Instrument selection for the assessment of peripheral arthritis in axial and peripheral spondyloarthritis: an ASAS project
Annals of the Rheumatic Diseases · 2026-11 · 85 (11) · 2087-2098
DOI: 10.1016/j.ard.2026.06.002 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Annals of the Rheumatic Diseases, 2026-11. Verfasst von Sofia Ramiro und 30 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; Department of Rheumatology, Zuyderland Medical Center, Heerlen…. Hauptthemen laut MEDLINE: Severity of Illness Index, Spondylarthritis, Axial Spondyloarthritis. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Assessment of SpondyloArthritis International Society.
Abstract (Originalsprache)
OBJECTIVES: To identify the most appropriate instrument to assess disease activity related to peripheral arthritis in axial spondyloarthritis (axSpA) and peripheral spondyloarthritis (pSpA) in clinical research. METHODS: This Assessment of Spondyloarthritis International Society (ASAS) project followed the Outcome Measures in Rheumatology (OMERACT) framework. Candidate instruments were identified through a systematic literature review (SLR). Domain match and feasibility were assessed by a working group (WG). A second SLR evaluated measurement properties (construct validity, test-retest reliability, responsiveness, clinical trial discrimination, and thresholds of meaning). Additional analyses were performed using individual patient data from randomised controlled trials (RCTs). Evidence was synthesised in summary of measurement properties tables, followed by a WG discussion and ASAS consensus voting. RESULTS: Composite disease activity instruments consistently outperformed single-item measures. Evidence from the second SLR was limited, particularly for axSpA with peripheral arthritis, but analyses of 13 RCTs strengthened the evidence. In both axSpA and pSpA, composite instruments, particularly the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Axial Spondyloarthritis Disease Activity Score (ASDAS), and Disease Activity index for Psoriatic Arthritis based on 44 joints (DAPSA44), showed better construct validity, responsiveness, and clinical trial discrimination than joint counts alone. Clinical trial discrimination was particularly better for DAPSA44, making it the best-performing instrument across all measurement properties. Following ASAS voting, DAPSA44 was the preferred instrument, receiving 92% agreement for axSpA and 97% for pSpA. CONCLUSIONS: DAPSA44 demonstrated the most adequate measurement performance across axSpA and pSpA and was endorsed by ASAS as the recommended instrument for assessing disease activity related to peripheral arthritis in pSpA clinical research. Future clinical trials and research studies should report DAPSA44 when analysing disease activity related to peripheral arthritis in SpA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; Department of Rheumatology, Zuyderland Medical Center, Heerlen, The Netherlands. Electronic address: sofiaramiro@gmail.com.
- Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands; Department of Rheumatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
- Rheumatology, University of Cordoba, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, Cordoba, Spain.
- Department of Rheumatology, Fondazione Policlinico Universitario Agostino Gemelli IRCSS, Rome, Italy; Catholic University of the Sacred Heart, Rome, Italy.
- Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands; Department of Rheumatology, Maastricht University Medical Centre, Maastricht, The Netherlands.
- Ruhr-Universität Bochum, Bochum, Germany; Rheumazentrum Ruhrgebiet, Herne, Germany.
Förderung
- Assessment of SpondyloArthritis International Society
Zitieren
APA
Ramiro, S., Capelusnik, D., López-Medina, C., Ortolan, A., Webers, C., Baraliakos, X., Bautista-Molano, W., Boonen, A., Van den Bosch, F., Carron, P., van Dam, M., van Gaalen, F., Gensler, L. S., Gossec, L., Hmamouchi, I., Kiltz, U., Kishimoto, M., Lowe, J., Machado, P. M., …, & Moltó, A. (2026). Instrument selection for the assessment of peripheral arthritis in axial and peripheral spondyloarthritis: an ASAS project. Annals of the Rheumatic Diseases, 85(11), 2087-2098. https://doi.org/10.1016/j.ard.2026.06.002
Vancouver
Ramiro S, Capelusnik D, López-Medina C, Ortolan A, Webers C, Baraliakos X, et al. Instrument selection for the assessment of peripheral arthritis in axial and peripheral spondyloarthritis: an ASAS project. Annals of the Rheumatic Diseases. 2026;85(11):2087-2098. doi:10.1016/j.ard.2026.06.002
BibTeX
@article{Ramiro2026,
author = {Ramiro, Sofia and Capelusnik, Dafne and López-Medina, Clementina and Ortolan, Augusta and Webers, Casper and Baraliakos, Xenofon and Bautista-Molano, Wilson and Boonen, Annelies and Van den Bosch, Filip and Carron, Philippe and van Dam, Maranda and van Gaalen, Floris and Gensler, Lianne S and Gossec, Laure and Hmamouchi, Ihsane and Kiltz, Uta and Kishimoto, Mitsumasa and Lowe, Jo and Machado, Pedro M and Navarro-Compán, Victoria and Nikiphorou, Elena and Vegas, Laura Pina and Poddubnyy, Denis and van de Sande, Marleen and Sepriano, Alexandre and Sieper, Joachim and Varkas, Gaelle and Mease, Philip and Landewé, Robert and van der Heijde, Désirée and Moltó, Anna},
title = {Instrument selection for the assessment of peripheral arthritis in axial and peripheral spondyloarthritis: an ASAS project},
journal = {Annals of the Rheumatic Diseases},
year = {2026},
volume = {85},
number = {11},
pages = {2087--2098},
doi = {10.1016/j.ard.2026.06.002}
}
EUVIMED